Brief: Vbi Vaccines Reports Full Year 2022 Financial Results
13/03/2023 12:17
March 13 (Reuters) -
* VBI VACCINES REPORTS FULL YEAR 2022 FINANCIAL RESULTS
* VBI VACCINES INC - AS OF DECEMBER 31, 2022 VBI HAD $62.6
MILLION
IN CASH COMPARED WITH $121.7 MILLION IN CASH AS OF DECEMBER 31,
2021
Source text for Eikon: ID:nBw9H0k6Xa
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on VBI Vaccines
See all newsBrief: VBI Vaccines Provides Update On Its Restructuring Proceedings
Brief: Vbi Vaccines Announces New Tumor Response Data From Ongoing Randomized Controlled Phase 2B Study Of Vbi-1901 In Recurrent Glioblastoma Patients
VBI Vaccines Inc reports results for the quarter ended in March - Earnings Summary
Brief: VBI Vaccines Says Entered At Market Offering Deal For Gross Proceeds Of Up To $8.5 Mln
Brief: VBI Vaccines Q1 Adjusted EPS USD -0.55